Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
53.91B | 55.31B | 51.96B | 49.89B | 44.76B | 37.61B | Gross Profit |
9.18B | 9.46B | 9.12B | 9.16B | 8.37B | 6.86B | EBIT |
927.00M | 1.09B | 877.00M | 997.00M | 491.00M | -129.00M | EBITDA |
1.15B | 4.36B | 1.17B | 1.35B | 957.00M | 296.01M | Net Income Common Stockholders |
2.83B | 2.99B | 810.00M | 905.00M | 723.00M | 109.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
12.30B | 9.08B | 6.31B | 6.23B | 5.17B | 5.14B | Total Assets |
31.76B | 32.76B | 29.54B | 28.86B | 25.31B | 23.00B | Total Debt |
99.00M | 47.00M | 241.00M | 325.00M | 531.00M | 738.00M | Net Debt |
-12.20B | -9.03B | -6.07B | -5.91B | -4.64B | -4.40B | Total Liabilities |
17.59B | 18.20B | 16.23B | 15.93B | 14.12B | 13.08B | Stockholders Equity |
14.17B | 14.55B | 13.30B | 12.93B | 11.19B | 9.92B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.00B | 555.00M | 1.38B | 313.00M | 1.09B | Operating Cash Flow |
0.00 | 2.05B | 684.00M | 1.47B | 437.00M | 1.24B | Investing Cash Flow |
0.00 | 890.00M | -332.00M | -86.00M | -137.00M | -138.00M | Financing Cash Flow |
0.00 | -383.00M | -277.00M | -336.00M | -281.00M | 558.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥8.20B | 2.74 | 1.91% | 6.45% | 269.38% | ||
73 Outperform | ¥12.89B | 11.12 | 2.27% | 7.79% | 22.67% | ||
72 Outperform | ¥9.49B | 10.56 | 3.69% | 9.49% | -3.05% | ||
70 Outperform | ¥4.06B | 10.81 | 4.78% | 15.88% | 115.04% | ||
62 Neutral | $6.82B | 11.05 | 2.80% | 4.32% | 2.67% | -24.92% |